- Home
- LSBK vs FBIO Comparison
LSBK vs FBIO Comparison
Compare LSBK & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- FBIO
- Stock Information
- Founded
- LSBK 1891
- FBIO 2006
- Country
- LSBK United States
- FBIO United States
- Employees
- LSBK N/A
- FBIO N/A
- Industry
- LSBK Savings Institutions
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- FBIO Health Care
- Exchange
- LSBK Nasdaq
- FBIO Nasdaq
- Market Cap
- LSBK 90.0M
- FBIO 88.7M
- IPO Year
- LSBK 2006
- FBIO N/A
- Fundamental
- Price
- LSBK $13.03
- FBIO $3.43
- Analyst Decision
- LSBK
- FBIO Strong Buy
- Analyst Count
- LSBK 0
- FBIO 2
- Target Price
- LSBK N/A
- FBIO $16.50
- AVG Volume (30 Days)
- LSBK 28.8K
- FBIO 1.3M
- Earning Date
- LSBK 10-22-2025
- FBIO 11-13-2025
- Dividend Yield
- LSBK 2.76%
- FBIO N/A
- EPS Growth
- LSBK 39.59
- FBIO N/A
- EPS
- LSBK 1.05
- FBIO N/A
- Revenue
- LSBK $26,488,000.00
- FBIO $59,301,000.00
- Revenue This Year
- LSBK N/A
- FBIO $51.59
- Revenue Next Year
- LSBK N/A
- FBIO $44.74
- P/E Ratio
- LSBK $12.48
- FBIO N/A
- Revenue Growth
- LSBK 1.75
- FBIO N/A
- 52 Week Low
- LSBK $11.50
- FBIO $1.33
- 52 Week High
- LSBK $13.48
- FBIO $3.97
- Technical
- Relative Strength Index (RSI)
- LSBK 55.76
- FBIO 63.91
- Support Level
- LSBK $12.96
- FBIO $3.26
- Resistance Level
- LSBK $13.26
- FBIO $3.97
- Average True Range (ATR)
- LSBK 0.19
- FBIO 0.31
- MACD
- LSBK -0.06
- FBIO 0.05
- Stochastic Oscillator
- LSBK 28.57
- FBIO 67.66
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.